Evidence mapPaperPMID 42042221Full record

ReviewMarine drugs2026

Recent Advances in NADES-Assisted Process Intensification Technologies for Sustainable Recovery of Microalgal Bioactives: Challenges and Future Prospectives.

Muhammad Shafiq, Sardar Ali, Liaqat Zeb

Abstract readReview
In one paragraph

Review in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammad ShafiqSchool of Medical Sciences, Shandong Xiehe University, Jinan 250109, China.
Sardar AliSchool of Medical Sciences, Shandong Xiehe University, Jinan 250109, China.
Liaqat ZebLaboratory of Bioresources and Pharmaceutical Chemistry, Department of Chemistry, University of Bergen, 5007 Bergen, Norway.ORCID 0000-0002-3657-5362

Funding

European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodow-ska-Curie grant agreement No. 101034309
6 · The paper itself

Abstract

Microalgae are increasingly recognized as renewable biofactories for producing high-value bioactive molecules. However, their industrial exploitation is limited by their rigid cell walls, metabolite heterogeneity, and the energy-intensive nature of the extraction processes. Recent advances in process-intensification technologies, including microwave-assisted, ultrasound-assisted, enzymatic, pressurized liquid, and supercritical CO

Indexed as

MicroalgaeMicrowavesSolventsSolventsbioactive compoundsmicroalgaenatural deep eutecticpre-treatmentprocess-intensification technologiessolvents

Identifiers

PMID42042221
PMCPMC13118078

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.